In the News April 23, 2020

Politico | How a Lack of FDA Inspections Will Likely Lead to Drug Rejections

Cathy Burgess comments on the U.S. Food and Drug Administration’s approach to approving drug applications amid COVID-19.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.